Literature DB >> 8690755

Differential expression of jackfruit-lectin-specific glycoconjugates in metastatic adenocarcinoma and reactive mesothelial cells-a diagnostic aid in effusion cytology.

K Sujathan1, S Kannan, P Remani, K R Pillai, B Chandralekha, N S Amma, M K Nair.   

Abstract

Distinguishing reactive mesothelial cells from adenocarcinoma cells in serous effusions on the basis of morphological criteria alone is often difficult. Interest has therefore been focused on identifying reliable methods to supplement the conventional cytological techniques. Plant lectins have been reported as diagnostic markers for malignant cells. We studied 51 aspirated samples of benign and malignant effusions using horseradish-peroxidase-conjugated jackfruit lectin. No significant difference was observed between the cells of pleural and peritoneal fluids. The reactively proliferated mesothelial cells of benign effusions showed a predominance of mild staining while moderate and intense staining was predominant in malignant effusions. Intense and irregular lectin binding was observed in macrophages irrespective of the cause of effusion. The lectin staining method therefore appears to have some clinical significance as an additional diagnostic aid for use in effusion cytology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690755     DOI: 10.1007/bf01212884

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

2.  Expression of lectin-specific cellular glycoconjugates during oral carcinogenesis.

Authors:  S Kannan; P Balaram; G J Chandran; M R Pillai; B Mathew; M K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Lectin-binding affinities of human breast tumors.

Authors:  C J Louis; T Sztynda; Z M Cheng; R G Wyllie
Journal:  Cancer       Date:  1983-10-01       Impact factor: 6.860

4.  Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma. A histochemical and immunohistochemical comparison.

Authors:  D J Bollinger; M R Wick; L P Dehner; S E Mills; P E Swanson; R E Clarke
Journal:  Am J Surg Pathol       Date:  1989-08       Impact factor: 6.394

5.  Immunocytochemical staining of cells in 153 pleural effusions with a panel of monoclonal antibodies and lectins.

Authors:  I V Abramenko; D F Gluzman; L M Sklyarenko; G V Pisnyachevskaya; V G Pinchouk
Journal:  Anticancer Res       Date:  1991 Mar-Apr       Impact factor: 2.480

6.  Tissue binding pattern of plant lectins in benign and malignant lesions of thyroid.

Authors:  T Vijayakumar; J Augustine; L Mathew; M A Aleykutty; M B Nair; P Remani; M K Nair
Journal:  J Exp Pathol       Date:  1992

7.  Histochemically demonstrable changes in cell surface carbohydrates of human germ cell tumors.

Authors:  S Teshima; S Hirohashi; Y Shimosato; K Kishi; Y Ino; K Matsumoto; T Yamada
Journal:  Lab Invest       Date:  1984-03       Impact factor: 5.662

8.  Lectin binding sites on human endocervix: a comparison with secretory and proliferative endometrium.

Authors:  Y Yen; M C Lee; M Salzmann; I Damjanov
Journal:  Anat Rec       Date:  1986-07

9.  Tissue binding patterns of lectins in premalignant and malignant lesions of the oral cavity.

Authors:  K K Vijayan; P Remani; V M Beevi; R Ankathil; T Vijayakumar; R Rajendran; J Augustine; D M Vasudevan
Journal:  J Exp Pathol       Date:  1987

10.  Tissue staining properties of lectins from the seeds of the jack fruit (Artocarpus integrifolia) and the winged bean (Psophocarpus tetragonolobus).

Authors:  T Vijayakumar; D Robertson; D McIntosh; J A Forrester
Journal:  J Exp Pathol       Date:  1987
View more
  1 in total

1.  Significance of a galactose specific plant lectin for the differential diagnosis of adenocarcinoma cells in effusion.

Authors:  K Sujathan; K Jayasree; P Remani
Journal:  J Cytol       Date:  2009-10       Impact factor: 1.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.